"Nejsou k\u00A0dispozici \u017E\u00E1dn\u00E9 adekv\u00E1tn\u00ED, dob\u0159e kontrolovan\u00E9 studie u t\u011Bhotn\u00FDch \u017Een s\u00A0kombinac\u00ED piperacilin/tazobaktam ani s piperacilinem nebo tazobaktamem samotn\u00FDm. Piperacilin a tazobaktam prostupuj\u00ED placentou. Kombinace piperacilin/tazobaktam se m\u00E1 v\u00A0t\u011Bhotenstv\u00ED pou\u017E\u00EDvat pouze pokud je to jasn\u011B indikov\u00E1no.\nPiperacilin se v\u00A0n\u00EDzk\u00FDch koncentrac\u00EDch vylu\u010Duje do mate\u0159sk\u00E9ho ml\u00E9ka. Koncentrace tazobaktamu v\u00A0lidsk\u00E9m mate\u0159sk\u00E9m ml\u00E9ce nebyly studov\u00E1ny. Nen\u00ED zn\u00E1m vliv t\u011Bchto l\u00E1tek na kojen\u00E9 d\u00EDt\u011B. Koj\u00EDc\u00ED \u017Eeny by m\u011Bly b\u00FDt l\u00E9\u010Deny pouze pokud je to jasn\u011B indikov\u00E1no. U kojence se m\u016F\u017Ee vyskytnout pr\u016Fjem a mykotick\u00E9 infekce sliznic, stejn\u011B jako senzitizace.\n"@cs . . "004.006" . . . "4.6 T\u011Bhotenstv\u00ED a kojen\u00ED"@cs .